Representation of pediatrics too limited to evaluate efficacy for Pfizer vaccine: Report
The representation of pediatric participants in the study population for the Pfizer-BioNTech Covid 19 vaccine is too limited to adequately ...
Read moreThe representation of pediatric participants in the study population for the Pfizer-BioNTech Covid 19 vaccine is too limited to adequately ...
Read moreNew Delhi: With COVID-19 vaccines soon to be available globally, Microsoft has launched a vaccine management platform for both government and ...
Read moreJohannesburg: South Africa's Chief Justice Mogoeng Mogoeng has come under fire after he said coronavirus vaccines currently causing some euphoria ...
Read moreWashington: Not since World War II has a single phenomenon dominated the news worldwide as the COVID-19 pandemic has in ...
Read moreWashington: The US has given a final nod for the emergency use of Pfizer's COVID-19 vaccine, paving the way for ...
Read moreSan Francisco: Facebook CEO Mark Zuckerberg has told his more than 50,000 employees that they will not be required to ...
Read moreNew Delhi: After Sputnik V vaccines clinical trial's preliminary results showed its efficacy at above 90 pe rcent, the Russian ...
Read moreNew Delhi: India's first indigenous mRNA vaccine candidate has received approval from the Drug Controller General of India to initiate ...
Read moreMelbourne: Australia stopped Friday the further development of a COVID-19 vaccine candidate. This decision was taken as several participants in ...
Read moreWashington: A US government advisory panel has recommended emergency approval for the Pfizer-BioNTech coronavirus vaccine. The advisory panel has underlined ...
Read more